Anti-tuberculosis site-specific oral delivery system that enhances rifampicin bioavailability in a fixed-dose combination with isoniazid

Por um escritor misterioso
Last updated 09 novembro 2024
Anti-tuberculosis site-specific oral delivery system that enhances  rifampicin bioavailability in a fixed-dose combination with isoniazid
Anti-tuberculosis site-specific oral delivery system that enhances  rifampicin bioavailability in a fixed-dose combination with isoniazid
Dual pH-Responsive Macrophage-Targeted Isoniazid Glycoparticles
Anti-tuberculosis site-specific oral delivery system that enhances  rifampicin bioavailability in a fixed-dose combination with isoniazid
Anti-tuberculosis site-specific oral delivery system that enhances
Anti-tuberculosis site-specific oral delivery system that enhances  rifampicin bioavailability in a fixed-dose combination with isoniazid
Pharmaceuticals, Free Full-Text
Anti-tuberculosis site-specific oral delivery system that enhances  rifampicin bioavailability in a fixed-dose combination with isoniazid
A biphasic nanohydroxyapatite/calcium sulphate carrier containing
Anti-tuberculosis site-specific oral delivery system that enhances  rifampicin bioavailability in a fixed-dose combination with isoniazid
Pharmaceutics, Free Full-Text
Anti-tuberculosis site-specific oral delivery system that enhances  rifampicin bioavailability in a fixed-dose combination with isoniazid
Anti-tuberculosis drug combination for controlled oral delivery
Anti-tuberculosis site-specific oral delivery system that enhances  rifampicin bioavailability in a fixed-dose combination with isoniazid
Targeted therapy in chronic diseases using nanomaterial-based drug
Anti-tuberculosis site-specific oral delivery system that enhances  rifampicin bioavailability in a fixed-dose combination with isoniazid
Advanced drug delivery and therapeutic strategies for tuberculosis
Anti-tuberculosis site-specific oral delivery system that enhances  rifampicin bioavailability in a fixed-dose combination with isoniazid
Pharmaceutics, Free Full-Text

© 2014-2024 progresstn.com. All rights reserved.